Latest News for: rtu

Edit

Hyloris Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets (Hyloris Developments SA)

Public Technologies 19 Jan 2026
). 19 Jan 2026 21.44 CET. Subscribe. Issuer. HYLORIS PHARMACEUTICALS SA. press-releasehylorisorionpantortueuropeen20260119.pdf.
Edit

Inside Information Hyloris Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets ENGLISH VERSION (Hyloris Developments SA)

Public Technologies 19 Jan 2026
) Hyloris Announces Strategic Partnership with Orion for its RTU Pantoprazole IV in European Markets ... The new ready-to-use pantoprazole intravenous formulation ("RTU IV") represents a ...
Edit

PAI Pharma Acquires Nivagen Pharmaceuticals, Expanding Domestic Sterile Injectable Manufacturing and Expanding Ready-To-Use ("RTU") Product Offering in the Hospital Market

PR Newswire 06 Jan 2026
Nivagen brings a rich pipeline of over 20 RTU injectable products, which complements PAI's existing sterile portfolio of approximately 10 products currently in development and 4 on the market.
Edit

Sanitation Strategies Launches LABSAN PEROXISAN™ TB RTU - A Ready-to-Use Hydrogen Peroxide Disinfectant with 1-Minute Kill on TB and Corynebacterium bovis

PR Newswire 31 Oct 2025
HOLT, Mich., Oct ... Continue Reading. Sanitation Strategies' Labsan Peroxisan TB Ready To Use ... LABSAN PEROXISAN™ TB RTU provides fast, effective with no dilution or mixing required ... Press Contact. Sanitation Strategies, LLCPhone. 1.877.494.4364Email ... 440k+ ... .
Edit

Japanese manufacturer launches dual-fuel commercial rooftop heat pump

PV Magazine 29 Oct 2025
The lineup includes a standard RTU, a heat pump with dual-fuel capability, and a dedicated outdoor air system (DOAS). The standard RTU comes in 13 sizes, with an integrated energy efficiency ratio (IEER) ranging from 16.6 to 21.3.
Edit

Hyloris and Orion Partner to Bring Tranexamic Acid RTU to Key European Markets (Hyloris Developments SA)

Public Technologies 28 Oct 2025
). 28 Oct 2025 07.01 CET. Subscribe. Issuer. HYLORIS PHARMACEUTICALS SA. pressreleasehylorisoriontxartueuropeen.pdf.
Edit

Inside Information Hyloris and Orion Partner to Bring Tranexamic Acid RTU to Key European Markets ENGLISH VERSION (Hyloris Developments SA)

Public Technologies 28 Oct 2025
The agreement grants Orion the rights to register, market, and commercialize Tranexamic Acid Intravenous Premix RTU (TXA RTU) in major European markets including Spain, Germany, France, Poland, the ...
  • 1
×